Works matching IS 11732563 AND DT 2020 AND VI 40 AND IP 4

Results: 9

Hospitalization Rates and Therapy Costs of German Schizophrenia Patients Who are Initiated on Long-Acting Injectable Medication: A Mirror-Image Study.

Published in:

Clinical Drug Investigation, 2020, v. 40, n. 4, p. 355, doi. 10.1007/s40261-020-00900-y

By:

Mahlich, Jörg;
Olbrich, Kerstin;
Wilk, Adrian;
Wimmer, Antonie;
Wolff-Menzler, Claus

Publication type:

Article

Direct Medical Costs of Spinal Muscular Atrophy in the Catalonia Region: A Population-Based Analysis.

Published in:

Clinical Drug Investigation, 2020, v. 40, n. 4, p. 335, doi. 10.1007/s40261-020-00897-4

By:

Darbà, Josep

Publication type:

Article

Loteprednol Etabonate (Submicron) Ophthalmic Gel 0.38%: A Review in Post-Operative Inflammation and Pain Following Ocular Surgery.

Published in:

Clinical Drug Investigation, 2020, v. 40, n. 4, p. 387, doi. 10.1007/s40261-020-00899-2

By:

Kang, Connie;
Keam, Susan J.;
Shirley, Matt;
Syed, Yahiya Y.

Publication type:

Article

Management of Left Ventricular Thrombi with Direct Oral Anticoagulants: Retrospective Comparative Study with Vitamin K Antagonists.

Published in:

Clinical Drug Investigation, 2020, v. 40, n. 4, p. 343, doi. 10.1007/s40261-020-00898-3

By:

Daher, Jessica;
Da Costa, Antoine;
Hilaire, Christophe;
Ferreira, Thomas;
Pierrard, Romain;
Guichard, Jean Baptiste;
Romeyer, Cécile;
Isaaz, Karl

Publication type:

Article

Neuroprotective Role of Oral Vitamin D Supplementation on Consciousness and Inflammatory Biomarkers in Determining Severity Outcome in Acute Traumatic Brain Injury Patients: A Double-Blind Randomized Clinical Trial.

Published in:

Clinical Drug Investigation, 2020, v. 40, n. 4, p. 327, doi. 10.1007/s40261-020-00896-5

By:

Sharma, Swapnil;
Kumar, Ashok;
Choudhary, Ajay;
Sharma, Shallu;
Khurana, Lipika;
Sharma, Neera;
Kumar, Vijender;
Bisht, Akansha

Publication type:

Article

Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple Sclerosis.

Published in:

Clinical Drug Investigation, 2020, v. 40, n. 4, p. 319, doi. 10.1007/s40261-020-00895-6

By:

Mantovani, Lorenzo G.;
Cozzolino, Paolo;
Cortesi, Paolo A.;
Patti, Francesco;
the SA.FE. study group;
Patti, F.;
Messina, S.;
Solaro, C.;
Amato, M. P.;
Bergamaschi, R.;
Bonavita, S.;
Bruno Bossio, R.;
Brescia Morra, V.;
Costantino, G. F.;
Cavalla, P.;
Centonze, D.;
Comi, G.;
Cottone, S.;
Danni, M.;
Francia, A.

Publication type:

Article

Mechanisms of Cannabinoids and Potential Applicability to Skin Diseases.

Published in:

Clinical Drug Investigation, 2020, v. 40, n. 4, p. 293, doi. 10.1007/s40261-020-00894-7

By:

Cintosun, Amber;
Lara-Corrales, Irene;
Pope, Elena

Publication type:

Article

Evaluation of the Efficacy of BI 425809 Pharmacotherapy in Patients with Schizophrenia Receiving Computerized Cognitive Training: Methodology for a Double-blind, Randomized, Parallel-group Trial.

Published in:

Clinical Drug Investigation, 2020, v. 40, n. 4, p. 377, doi. 10.1007/s40261-020-00893-8

By:

Harvey, Philip D.;
Bowie, Christopher R.;
McDonald, Sean;
Podhorna, Jana

Publication type:

Article

Budget Impact Analysis of Dalbavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections in Three European Countries.

Published in:

Clinical Drug Investigation, 2020, v. 40, n. 4, p. 305, doi. 10.1007/s40261-020-00891-w

By:

Marcellusi, Andrea;
Bini, Chiara;
Andreoni, Massimo;
Sarmati, Loredana;
Espin, Jaime;
Horcajada, Juan P.;
Czypionka, Thomas;
Andretta, Davide;
Sciattella, Paolo;
Favato, Giampiero;
Mennini, Francesco S.

Publication type:

Article